Insurers and
Lab Partners

 

PredictSURE IBD™ is the first validated prognostic test for IBD with measurable economic and health benefits.

How can you help your physicians manage their Crohn’s Disease and ulcerative colitis patients better?

​

How about a first and only prognostic test?

Towards the right treatment, for the right patient, at the right time 

​

• For Crohn’s disease and ulcerative colitis patients 

• Stratify patients into high and low risk of early and frequent flares 

• Exploit the window of opportunity at diagnosis to impact on outcomes

• High risk patients may benefit from early aggressive therapy